Top Clinical Trials companies in the world by Revenue

This ranking features the top 418 Clinical Trials companies in the world ranked by Revenue, totalling a Revenue of USD 66.25 B, for January 15, 2025.

Global

Clinical Trials

#	Name	Revenue	Reported Date	Stock Price	Change	Country
1	Vertex Pharmaceuticals Incorporated 1 VRTX	USD 10.61 B	Sept. 30, 2024	USD 411.66	-0.41%	United States
2	ICON Public Limited Company 2 ICLR	USD 8.12 B	Dec. 31, 2023	USD 200.24	-8.14%	Ireland
3	BioNTech SE 3 22UA.F	USD 4.22 B	Dec. 31, 2023	USD 116.36	-0.45%	Germany
4	Incyte Corporation 4 INCY	USD 4.08 B	Sept. 30, 2024	USD 71.93	-0.61%	United States
5	Charles River Laboratories International, Inc. 5 CRL	USD 4.06 B	Sept. 28, 2024	USD 178.08	-6.34%	United States
6	Cingulate Inc. 6 CING	USD 3.85 B	Sept. 30, 2023	USD 4.62	-0.22%	United States
7	Genmab A/S 7 GMAB.CO	USD 2.44 B	Dec. 31, 2023	USD 216.88	1.28%	Denmark
8	Neurocrine Biosciences, Inc. 8 NBIX	USD 2.24 B	Sept. 30, 2024	USD 139.51	-2.46%	United States
9	Alnylam Pharmaceuticals, Inc. 9 ALNY	USD 2.09 B	Sept. 30, 2024	USD 240.51	-6.88%	United States
10	Exelixis, Inc. 10 EXEL	USD 2.08 B	Sept. 27, 2024	USD 35.65	0.99%	United States
11	Medpace Holdings, Inc. 11 MEDP	USD 2.07 B	Sept. 30, 2024	USD 330.91	-5.99%	United States
12	Sarepta Therapeutics, Inc. 12 SRPT	USD 1.64 B	Sept. 30, 2024	USD 118.83	0.34%	United States
13	Hangzhou Tigermed Consulting Co., Ltd. 13 3347.HK	USD 1.04 B	Dec. 31, 2023	USD 3.72	2.09%	China
14	HUTCHMED (China) Limited 14 0013.HK	USD 838.00 M	Dec. 31, 2023	USD 3.02	2.59%	Hong Kong
15	Shanghai Henlius Biotech, Inc. 15 2696.HK	USD 759.87 M	Dec. 31, 2023	USD 2.59	-10.24%	China
16	Guardant Health, Inc. 16 GH	USD 692.26 M	Sept. 30, 2024	USD 37.46	-1.68%	United States
17	Supernus Pharmaceuticals, Inc. 17 SUPN	USD 651.97 M	Sept. 30, 2024	USD 37.82	0.66%	United States
18	NeoGenomics, Inc. 18 NEO	USD 644.12 M	Sept. 30, 2024	USD 13.78	9.11%	United States
19	Akeso, Inc. 19 9926.HK	USD 637.52 M	Dec. 31, 2023	USD 7.28	2.32%	China
20	Corcept Therapeutics Incorporated 20 CORT	USD 628.55 M	Sept. 30, 2024	USD 51.66	1.18%	United States
21	Intra-Cellular Therapies, Inc. 21 ITCI	USD 612.92 M	Sept. 30, 2024	USD 126.89	-0.24%	United States
22	Legend Biotech Corporation 22 LEGN	USD 520.18 M	Sept. 30, 2024	USD 31.64	-2.65%	United States
23	Australian Clinical Labs Limited 23 ACL.AX	USD 459.88 M	June 30, 2024	USD 2.14	0.82%	Australia
24	Blueprint Medicines Corporation 24 BPMC	USD 434.41 M	Sept. 30, 2024	USD 102.56	-0.77%	United States
25	Denali Therapeutics Inc. 25 DNLI	USD 340.81 M	Sept. 30, 2023	USD 18.74	-4.34%	United States
26	Axsome Therapeutics, Inc. 26 AXSM	USD 338.46 M	Sept. 30, 2024	USD 84.60	-5.23%	United States
27	Telix Pharmaceuticals Limited 27 TLX.AX	USD 338.23 M	Dec. 31, 2023	USD 15.47	4.25%	Australia
28	Joinn Laboratories(China)Co.,Ltd. 28 6127.HK	USD 334.73 M	Dec. 31, 2023	USD 1.06	2.98%	China
29	Protagonist Therapeutics, Inc. 29 PTGX	USD 323.80 M	Sept. 30, 2024	USD 36.67	-1.26%	United States
30	Castle Biosciences, Inc. 30 CSTL	USD 311.88 M	Sept. 30, 2024	USD 25.46	-2.64%	United States
31	Mirum Pharmaceuticals, Inc. 31 MIRM	USD 307.03 M	Sept. 30, 2024	USD 43.32	-1.54%	United States
32	Zai Lab Limited 32 9688.HK	USD 266.72 M	Dec. 31, 2023	USD 2.49	0.18%	China
33	TG Therapeutics, Inc. 33 TGTX	USD 264.79 M	Sept. 30, 2024	USD 29.74	7.48%	United States
34	Arcus Biosciences, Inc. 34 RCUS	USD 263.00 M	Sept. 30, 2024	USD 13.82	-0.79%	United States
35	Immunocore Holdings plc 35 IMCR	USD 249.43 M	Dec. 31, 2023	USD 28.56	-4.90%	United Kingdom
36	Krystal Biotech, Inc. 36 KRYS	USD 241.52 M	Sept. 30, 2024	USD 142.64	-5.10%	United States
37	Travere Therapeutics, Inc. 37 TVTX	USD 203.45 M	Sept. 30, 2024	USD 17.07	-8.18%	United States
38	Xeris Biopharma Holdings, Inc. 38 XERS	USD 187.36 M	Sept. 30, 2024	USD 3.20	-2.44%	United States
39	GNI Group Ltd. 39 2160.T	USD 184.34 M	Dec. 31, 2023	USD 19.77	1.11%	Japan
40	Adaptive Biotechnologies Corporation 40 ADPT	USD 177.28 M	Sept. 30, 2024	USD 6.07	-6.04%	United States
41	Shin Nippon Biomedical Laboratories, Ltd. 41 2395.T	USD 174.76 M	March 31, 2024	USD 10.78	1.91%	Japan
42	Voyager Therapeutics, Inc. 42 VYGR	USD 163.78 M	Sept. 30, 2024	USD 5.05	-4.36%	United States
43	Sutro Biopharma, Inc. 43 STRO	USD 160.96 M	Sept. 30, 2024	USD 1.72	-3.91%	United States
44	Agenus Inc. 44 AGEN	USD 160.43 M	Sept. 30, 2024	USD 3.15	-0.32%	United States
45	Rigel Pharmaceuticals, Inc. 45 RIGL	USD 157.47 M	Sept. 30, 2024	USD 16.69	-2.46%	United States
46	Arcellx, Inc. 46 ACLX	USD 155.82 M	Sept. 30, 2024	USD 64.65	-4.02%	United States
47	RemeGen Co., Ltd. 47 9995.HK	USD 151.57 M	Dec. 31, 2023	USD 1.59	2.46%	China
48	Poseida Therapeutics, Inc. 48 PSTX	USD 150.86 M	Sept. 30, 2024	USD 9.50	NA	United States
49	MacroGenics, Inc. 49 MGNX	USD 141.33 M	Sept. 30, 2024	USD 3.04	-4.10%	United States
50	Kindstar Globalgene Technology, Inc. 50 9960.HK	USD 136.24 M	Dec. 31, 2023	USD 0.15	-0.02%	China

1 2 3 4 … 9

Frequently Asked Questions

Which Clinical Trials company has the highest Revenue ?

The Clinical Trials company with the highest Revenue is Vertex Pharmaceuticals Incorporated (NasdaqGS: VRTX) at USD 10.61 B.
Which Clinical Trials company has the lowest Revenue ?

The Clinical Trials company with the lowest Revenue is PDS Biotechnology Corporation (NasdaqCM: PDSB) at USD 0.00.

What are the top 10 Clinical Trials companies by Revenue ?

The top 10 Clinical Trials companies the Global by Revenue are Vertex Pharmaceuticals Incorporated, ICON Public Limited Company, BioNTech SE, Incyte Corporation, Charles River Laboratories International, Inc., Cingulate Inc., Genmab A/S, Neurocrine Biosciences, Inc., Alnylam Pharmaceuticals, Inc. and Exelixis, Inc..
What are the bottom 10 Clinical Trials companies by Revenue ?

The bottom 10 Clinical Trials companies by Revenue are PDS Biotechnology Corporation, Savara Inc., Cullinan Oncology, Inc., Pharvaris N.V., Kodiak Sciences Inc., Calidi Biotherapeutics, Inc., Iterum Therapeutics plc, Chemomab Therapeutics Ltd., Disc Medicine, Inc. and ImmuPharma plc.